
Second Independent Proxy Advisor Glass Lewis Recommends ASA Gold and Precious Metals Shareholders Vote FOR Saba Capital's Proposals to Expand the Board
In its full report, Glass Lewis outlined its significant governance concerns regarding the actions of legacy directors Mary Joan Hoene and William Donovan and criticized their repeated adoption of poison pills, writing: 1
'The adoption of multiple consecutive rights plans, each immediately following the expiration of the previous one, undermines confidence in the board's willingness to comply with both the spirit and letter of the law.'
'The continued use of poison pills under these conditions raises material governance concerns that underscore the need for independent oversight and board rebalancing.'
'In our view, while concerns about activist-driven change warrant careful scrutiny, they do not justify recurring violations of regulatory or court guidance or the exclusion of validly elected board members from fundamental decision-making processes.'
'…the continued use of shareholder rights plans by a board committee composed solely of Legacy Directors, even after adverse legal rulings, raises significant governance concerns that we believe warrant shareholder attention and correction at this juncture.'
Glass Lewis also highlighted Maryann Bruce's extensive qualifications and the value she would deliver to the Board as an independent director committed to upholding strong governance principles, stating:
'In our view, her credentials meet, if not exceed, the bar typically expected for public fund trustees and suggest that she would be capable of adding substantial value in a fiduciary role. It's also notable that none of Axel Merk's public materials appear to raise any specific concerns regarding Ms. Bruce's background, experience and qualifications.'
'…we find no evidence suggesting that Ms. Bruce lacks independence or would be beholden to Saba Capital's agenda. On the contrary, her public statements suggest a clear intent to bridge the current divide and uphold core governance principles.'
'…Ms. Bruce brings an appropriate mix of fund governance expertise, fiduciary experience, and independence to help resolve the present impasse and guide the Fund through its next phase.'
'We believe the nomination of Maryann Bruce as an independent fifth director represents a reasonable and well-structured path to restore board functionality ahead of the 2025 AGM, without preempting shareholder input on longer-term strategic matters.'
Glass Lewis also emphasized the importance of Maryann Bruce's role to break the current Board deadlock and highlighted her public commitment not to pursue any strategic changes unless they are approved by shareholders at the next Annual Meeting:
'…Ms. Bruce has publicly committed to serving only through that meeting and has stated she will not seek to alter the Fund's investment strategy or terminate the current investment adviser during that period.'
'She has also emphasized that decisions of consequence should be made only by the full board and that any consideration of strategic change – such as replacing Merk as the Fund's investment adviser – would only occur after shareholder endorsement at the next AGM and following a thorough review.'
'…Ms. Bruce has publicly emphasized her role as an independent director who will act as a neutral facilitator to break the current deadlock. Shareholders will retain full authority to assess and vote on any future strategic platform at the Fund's 2025 AGM scheduled for later this year.'
Boaz Weinstein, Founder and Chief Investment Officer of Saba, commented:
'Two leading proxy advisors have now highlighted the deep governance failures of ASA's legacy directors, Mary Joan Hoene and William Donovan. From breaking federal law to silencing the voices of their fellow directors, Hoene and Donovan have gone to extreme lengths to disenfranchise shareholders. If they're not held accountable now, where does it end?
ISS and Glass Lewis agree, the solution is clear: we must return the Board to five members and appoint Maryann Bruce as an independent director committed to strong governance. We urge ASA shareholders to vote for Saba's proposals on the GOLD proxy card to bring independent oversight to the Board and protect the rights of all shareholders.
Despite Axel Merk's attempts to mislead shareholders, Friday's vote is simply about restoring board function and ensuring ASA holds its annual meeting. It is not a vote on changing the Fund's strategy or advisor – something both ISS and Glass Lewis recognized.'
Shareholders should vote on the GOLD proxy card today FOR both proposals.
Saba Capital Management, L.P. is a global alternative asset management firm that seeks to deliver superior risk-adjusted returns for a diverse group of clients. Founded in 2009 by Boaz Weinstein, Saba is a pioneer of credit relative value strategies and capital structure arbitrage. Saba has offices in New York City and London. Learn more at www.sabacapital.com.
1 Permission to quote Glass Lewis was neither sought nor obtained.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Hims & Hers Stock Nosedives After Q2 Revenue Miss Despite 73% Growth
Aug 5 - Hims & Hers Health (NYSE:HIMS) shares took a hit on Tuesday, dropping more than 10% in early trading. The telehealth company missed Wall Street's Q2 revenue expectations, even though it posted impressive growth. Warning! GuruFocus has detected 5 Warning Sign with HIMS. Revenue jumped 73% year-over-year to $544.8 million, but still fell short of the expected $552 million. On the earnings front, adjusted EPS came in at 17 cents, beating the 15 cents estimate. The company also delivered $82 million in adjusted EBITDA, more than doubling from last year's $39.3 million. Despite the strong profit metrics, investors remained cautious, likely due to revenue miss and ongoing concerns tied to its compounded GLP-1 offerings. Hims & Hers continues to face scrutiny for distributing cheaper, unapproved versions of popular diabetes and weight-loss drugs. The FDA had previously resolved supply issues, yet some telehealth players, including Hims, keep offering personalized doses. For Q3, the company guides revenue between $570 million$590 million, in line with expectations, but EBITDA guidance ($60M$70M) fell short of StreetAccount's $77.1 million forecast. Hims will need to convince investors that fast growth won't be overshadowed by regulatory headwinds. Is HIMS Stock a Buy Now? Based on the one year price targets offered by 13 analysts, the average target price for Hims & Hers Health Inc is $48.49 with a high estimate of $85.00 and a low estimate of $28.00. The average target implies a downside of -23.46% from the current price of $63.35. Based on GuruFocus estimates, the estimated GF Value for Hims & Hers Health Inc in one year is $36.01, suggesting a downside of -43.16% from the current price of $63.35. Gf value is Gurufocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. For deeper insights, visit the forecast page. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 minutes ago
- Yahoo
Should You Consider Adding Loar Holdings (LOAR) to Your Portfolio?
Baron Funds, an investment management company, released its 'Baron Global Advantage Fund' investor letter for the second quarter of 2025. A copy of the letter can be downloaded here. In the second quarter, the fund returned 22.7% (Institutional Shares), compared to the MSCI ACWI Index's (the Index) 11.5% gain and the MSCI ACWI Growth Index's 17.3% gain. The Fund is up 11.2%, year-to-date, compared to gains of 10.1% and 9.3% for the benchmarks, respectively. In addition, please check the fund's top five holdings to know its best picks in 2025. In its second-quarter 2025 investor letter, Baron Global Advantage Fund highlighted stocks such as Loar Holdings Inc. (NYSE:LOAR). Incorporated in 2017, Loar Holdings Inc. (NYSE:LOAR) designs, manufactures, and markets aerospace and defense components for aircraft and aerospace and defense systems. The one-month return of Loar Holdings Inc. (NYSE:LOAR) was -7.81%, and its shares gained 19.68% of their value over the last 52 weeks. On August 4, 2025, Loar Holdings Inc. (NYSE:LOAR) stock closed at $72.68 per share, with a market capitalization of $6.8 billion. Baron Global Advantage Fund stated the following regarding Loar Holdings Inc. (NYSE:LOAR) in its second quarter 2025 investor letter: "We recently initiated a position in Loar Holdings Inc. (NYSE:LOAR), a niche aerospace parts manufacturer founded in 2012. Loar boasts an 85% proprietary product portfolio, with over 50% of its revenue derived from the high-margin aftermarket channel. Proprietary, aftermarket focused products are among the strongest business models in the aerospace and defense industry, as evidenced by the success of TransDigm. This segment is attractive for several reasons. First, the aerospace industry is growing, with passenger miles increasing faster than GDP at roughly 4% per year. Second, Loar benefits from strong pricing power due to the critical nature of its components, the absence of substitute products (owing to high proprietary content), and high barriers to entry. These components are high-risk, low-cost for airlines, which are reluctant to compromise safety for minimal cost savings (most Loar parts cost less than $1,000). Additionally, substitution of existing parts requires a lengthy and costly FAA approval process, which is often uneconomical for competitors to pursue given the high-variability, low-volume nature of aircraft components (millions of components per aircraft, each with low production volumes). These factors should enable Loar to achieve approximately 10% organic revenue growth and 15% adjusted EBITDA growth. Furthermore, beyond these value drivers, Loar is executing a disciplined acquisition strategy, successfully integrating 17 acquisitions over the past 13 years. A skilled machinist inspecting a precision bearing for a aerospace/defense application. Loar Holdings Inc. (NYSE:LOAR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 20 hedge fund portfolios held Loar Holdings Inc. (NYSE:LOAR) at the end of the first quarter, compared to 32 in the previous quarter. While we acknowledge the potential of Loar Holdings Inc. (NYSE:LOAR) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Loar Holdings Inc. (NYSE:LOAR) and shared the list of best aerospace and defense stocks to invest in. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
2 minutes ago
- Yahoo
Does Taiwan Semiconductor Manufacturing Company Limited (TSM) have an Unmatched Competitive Position in Leading-Edge Semiconductor Manufacturing?
Baron Funds, an investment management company, released its 'Baron Global Advantage Fund' investor letter for the second quarter of 2025. A copy of the letter can be downloaded here. In the second quarter, the fund returned 22.7% (Institutional Shares), compared to the MSCI ACWI Index's (the Index) 11.5% gain and the MSCI ACWI Growth Index's 17.3% gain. The Fund is up 11.2%, year-to-date, compared to gains of 10.1% and 9.3% for the benchmarks, respectively. In addition, please check the fund's top five holdings to know its best picks in 2025. In its second-quarter 2025 investor letter, Baron Global Advantage Fund highlighted stocks such as Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM). Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) manufactures, packages, tests, and sells integrated circuits and other semiconductor devices. The one-month return of Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) was 4.89%, and its shares gained 53.81% of their value over the last 52 weeks. On August 4, 2025, Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) stock closed at $239.00 per share, with a market capitalization of $1.24 trillion. Baron Global Advantage Fund stated the following regarding Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) in its second quarter 2025 investor letter: "Our largest add during the quarter was Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) as we continued to build our position. We believe that while near-term uncertainty due to tariffs and macro remains heightened, TSMC's competitive positioning in leading-edge semiconductor manufacturing remains unmatched. We also believe that TSMC will benefit from a long duration of growth as the adoption of AI proliferates across industries – and the recent developments in the space which we discussed above (e.g. removal of the AI Diffusion rule, accelerated adoption of reasoning-based AI inference, and the expansion of scaling laws) will serve to further accelerate the adoption of AI. We also like the fact that TSMC will benefit regardless of the ultimate market share split between GPUs and application-specific integrated circuits. It's the ultimate "arms dealer" to AI." A close-up of a complex network of integrated circuits used in logic semiconductors. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is in 9th position on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 187 hedge fund portfolios held Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) at the end of the first quarter, which was 186 in the previous quarter. While we acknowledge the potential of Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) and shared the list of best stocks to buy for the next 6 months. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data